An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: Results from the IDIProst® Gold Study

  • Tommaso Cai | ktommy@libero.it Department of Urology, Santa Chiara Regional Hospital, Trento, Italy.
  • Giuseppe Morgia Department of Urology and Department of Hygiene and Public Health, University of Catania, Catania, Italy.
  • Giuseppe Carrieri Department of Urology and Renal Transplantation, University of Foggia, Foggia, Italy.
  • Carlo Terrone Division of Urology, ASO Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy.
  • Ciro Imbimbo Department of Urology, University Federico II of Naples, Italy.
  • Paolo Verze Department of Urology, University Federico II of Naples, Italy.
  • Vincenzo Mirone Department of Urology, University Federico II of Naples, Italy.
  • IDIProst® Gold Study Group

Abstract

Objective. The relationship between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) has recently received increased attention. The aim of this study was to evaluate the efficacy of the Alfa-5® association of Serenoa repens, Pinus massoniana Bark Extract (PMBE) and Crocus sativus (IDIProst® Gold) in improvement of patient’s quality of life, when compared with Serenoa repens alone. Materials and Methods. All patients with clinical and instrumental diagnosis of LUTS due to Benign Prostatic Hyperplasia (BPH) and ED, attending 5 Italians Urological Institutions from May to December 2012 were enrolled in this prospective, multicentre, phase 3 study. Participants were assigned to receive oral capsules of IDIProst® Gold (one capsule q24 h) or Serenoa repens 320 mg (one capsule q24h) for 3 months. Clinical and instrumental analyses were carried out at the enrolment and at the end of therapy. IPSS, IIEF-5 and SF-36 questionnaires have been used. The main outcome measure was the improvement of quality of life at the end of the whole study period. Results. 129 (mean age 45-71 ± 4.36) men were randomly allocated to IDIProst® Gold (n = 83) or Serenoa repens (n = 46). The baseline questionnaire mean scores were 17.1 ± 6.4, 14.9 ± 3.7, 96.3 ± 1.2 for IPSS, IIEF-5 and SF-36, respectively. At the follow-up examination, statistically significant differences have been reported in terms of IPSS (11.9 vs 13.8; p < 0.001), IIEF-5 and SF-36 mean scores (19.3 vs 16.1; 99.7 vs 96.3; p < 0.003; p < 0.001). Moreover, statistically significant differences were then reported between the two visits, in terms of IPSS, IIEF-5 and SF-36 scores (p < 0.003; p < 0.001; p < 0.001), only in the IDIProst® Gold group. Conclusions. In conclusions, we found that IDIProst® Gold significantly improve the quality of life of patients affected by LUTS due to BPH and ED, specifically in terms of sexual function, highlighting that a better sexual quality of life is correlated with an higher overall quality of life regardless of the urinary function.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2013-12-31
Info
Issue
Section
Original Papers - Prostate
Keywords:
BPH, LUTS, Erectile Dysfunction, Serenoa repens, Crocus sativus, Quality of Life
Statistics
  • Abstract views: 3710

  • PDF: 2215
How to Cite
Cai, T., Morgia, G., Carrieri, G., Terrone, C., Imbimbo, C., Verze, P., Mirone, V., & Gold Study Group, I. (2013). An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: Results from the IDIProst® Gold Study. Archivio Italiano Di Urologia E Andrologia, 85(4), 184-189. https://doi.org/10.4081/aiua.2013.4.184

Most read articles by the same author(s)

1 2 > >>